10 active trials 5 recruiting 4 Phase 3 4 disease areas
| Phase 1 | 2 | |
| Phase 2 | 2 | |
| Phase 2/3 | 1 | |
| Phase 3 | 3 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06425900 | A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by… | Acne Vulgaris | Active, Not Recruiting | 2026-01-21 |
| Phase 3 | ||||
| NCT06611163 | A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects… | Moderate to Severe Genital Psoriasis | Active, Not Recruiting | 2026-03-25 |
| NCT04314531 | Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With… | Active Psoriatic Arthritis | Active, Not Recruiting | 2026-03-10 |
| NCT04991116 | Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic… | Psoriatic Arthritis | Active, Not Recruiting | 2026-03-05 |
| Phase 2/3 | ||||
| NCT03997786 | A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis | Moderate-to-severe Chronic Plaque Psoriasis | Active, Not Recruiting | 2026-04-15 |
| Phase 2 | ||||
| NCT05422911 | Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer. | Metastatic Cancer | Recruiting | 2026-06-15 |
| NCT07282743 | Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus | Type II Diabetes Mellitus | Recruiting | 2026-03-18 |
| Phase 1 | ||||
| NCT07729579 | An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper… | Actinic Keratosis (AK) | Recruiting | 2026-08-13 |
| NCT07385547 | Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency | Type II Diabetes Mellitus | Recruiting | 2026-03-13 |
| Not specified | ||||
| NCT03992729 | Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With… | Pregnancy Related | Recruiting | 2026-01-21 |
Psoriasis (2) · Psoriatic Arthritis (2) · Diabetes (2) · Prostate Cancer (1)